financetom
Business
financetom
/
Business
/
Dentsply Sirona Finance Chief Glenn Coleman to Resign
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dentsply Sirona Finance Chief Glenn Coleman to Resign
Aug 20, 2024 4:14 AM

06:44 AM EDT, 08/20/2024 (MT Newswires) -- Dentsply Sirona ( XRAY ) said Tuesday its Chief Financial Officer Glenn Coleman will resign, effective Nov. 7, to take an executive position at another public company.

The company said it has initiated the search for its next CFO with the help of an executive search firm.

Price: 24.62, Change: -0.92, Percent Change: -3.60

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Avanos Medical Acquires Nexus Medical for Undisclosed Sum
Avanos Medical Acquires Nexus Medical for Undisclosed Sum
Sep 15, 2025
07:40 AM EDT, 09/15/2025 (MT Newswires) -- Avanos Medical ( AVNS ) said Monday that it has acquired privately-held medical device company, Nexus Medical, for an undisclosed sum. The company said it financed the transaction with available cash and expects it to be immediately accretive to revenue growth and earnings per share. ...
Top Premarket Gainers
Top Premarket Gainers
Sep 15, 2025
07:41 AM EDT, 09/15/2025 (MT Newswires) -- Helius Medical Technologies ( HSDT ) stock was up more than 300% pre-bell Monday following a 3.1% gain in the previous session. Monte Rosa Therapeutics ( GLUE ) shares were 60% higher after the company said it formed a collaboration with Novartis (NVS) to develop degraders for the treatment of immune-mediated diseases. Envirotech...
Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics
Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics
Sep 15, 2025
(Reuters) - Swiss drugmaker Novartis and drug developer Monte Rosa Therapeutics ( GLUE ) signed a licensing deal worth up to $5.7 billion on Monday to develop drugs for immune-mediated diseases. Under the agreement, Monte Rosa Therapeutics ( GLUE ) will receive an upfront payment of $120 million and could earn up to $5.7 billion in total, including milestone payments...
USA Compression Partners Plans to Offer $750 Million Senior Notes Due 2033 in Private Placement
USA Compression Partners Plans to Offer $750 Million Senior Notes Due 2033 in Private Placement
Sep 15, 2025
07:42 AM EDT, 09/15/2025 (MT Newswires) -- USA Compression Partners ( USAC ) said Monday it plans to offer, together with its USA Compression Finance unit, $750 million of senior unsecured notes due 2033 in a private placement to eligible buyers. The company said it will use the net proceeds, along with borrowings under its credit agreement, to redeem all...
Copyright 2023-2026 - www.financetom.com All Rights Reserved